Need of cost-effective vaccines in developing countries: What plant biotechnology can offer?

ABSTRACT: To treat current infectious diseases, different therapies are used that include drugs or vaccines or both. Currently, the world is facing an increasing problem of drug resistance from many pathogenic microorganisms. In majority of cases, when vaccines are used, formulations consist of live attenuated microorganisms. This poses an additional risk of infection in immunocompromised patients and people suffering from malnutrition in developing countries. Therefore, there is need to improve drug therapy as well as to develop next generation vaccines, in particular against infectious diseases with highest mortality rates. For patients in developing countries, costs related to treatments are one of the major hurdles to reduce the disease burden. In many cases, use of prophylactic vaccines can hel

SUBMITTER: Waheed MT 

PROVIDER: S-EPMC4722051 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature